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Objective: Bacterial vaginosis (BV) is a known risk factor for postoperativeinfection following abdominal hyster-
ectomy. Vaginal bacterial flora scored as intermediate has been shown to have the same risk of postoperative
infection as BV.
Methods: Women undergoingtotalabdominal hysterectomyforbenigndiseaseswereopen-randomizedaccord-
ingtoZelentoeithertreatmentwithmetronidazolerectallyforatleast4 daysornotreatment.Atthepreoperative
gynecologicalexamination a vaginal smear was collected and Gram stained. Women with BV or intermediate flora
were merged to one group called abnormal vaginal flora.
Results: In total 213 women were randomized to treatment or no treatment. After exclusion of 71 women, 142
women were eligible for analysis. Among the 59 women diagnosed with abnormal vaginal flora there were no
vaginalcuffinfectionsinthetreatedarm,comparedwith27% inthe ‘notreatment’arm(p < 0.01). Treatmentalso
reduced the vaginal cuff infection rate from 9.5 to 2% among the 83 women with lactobacilli flora. However,
this difference was not statistically significant. Treatment had no effect on the rate of wound infections.
Intention-to-treat analysis showed a significant reduction in vaginal cuff infections among women randomized
to treatment.
Conclusion: Pre- and postoperative treatment for at least 4 days with metronidazole rectally reduces
significantly vaginal cuff infection among women with abnormal vaginal flora.
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TREATMENT; INTERMEDIATE FLORA
Total abdominal hysterectomy is the most
common procedure for removing the uterus. Pre-
operative administration of antibiotics has been
recommended for vaginal hysterectomy, but not
always for abdominal hysterectomy1. Results from
a meta-analysis2, published in 1993, showed that
21.1% of patients who did not receive antibiotic
prophylaxishad a serious infection after abdominal
hysterectomy, whereas only 9% of women given
preoperative antibioticsprior to abdominalhyster-
ectomy had serious postoperative infection. This
practice of preoperative antibiotic administration
has not been accepted as good clinical practice
in Scandinavia, due to the fact that several
Scandinavian studies showed little effect of pre-
operative antibiotic prophylaxis on postoperative
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133morbidity3–6. Mittendorf 2 showed that metroni-
dazole was the drug of choice for prophylactic
antibiotics, but other authors have suggested
second-generation cephalosporins as a better
choice.
Bacterial vaginosis (BV) is a condition in which
the vaginal flora is characterized by a 1000–
10 000-fold increase in concentration of various
bacteria, including anaerobic bacteria, Gardnerella
vaginalis, mycoplasmas and Mobiluncus, which
primarily affect menstruating women. However,
the vaginal flora of women without BV differs
considerably, from a lactobacilli-dominated flora
to havingnoidentifiable lactobacilli. Womenwith
no or few lactobacilli seen by microscopy, and not
having a diagnosis of BV, are said to have ‘inter-
mediate flora’, i.e. a flora between normal and
BV7. Diagnostic difficulties regarding vaginosis
arise when trying to differentiate BV from inter-
mediate flora and not so much when differentia-
ting between normal lactobacilli flora and BV or
intermediate flora. Intermediate flora seems to be
of similar clinical significance as BV8–10. Thus, it
has been suggested that intermediate flora and
BV should be merged to one single group called
‘abnormal vaginal flora’11.
Four studies are available concerning the risk
of postoperative pelvic infection after abdominal
hysterectomy among women with BV12–15. The
first study12 comprised 161 women scheduled for
abdominal hysterectomy for benign reasons.
Women with BV had a relative risk (RR) of 3.4
(95% confidence interval (CI) 1.5–6.7) for cuff
cellulitis compared with women who had a nega-
tive preoperative diagnosis of BV. In the second
study13, 70 women undergoing abdominal hyster-
ectomy for benign reasons with exclusion of
postmenopausalwomen showeda RR of4.4 (95%
CI 1.4–13.3) for developing postoperative infec-
tion if the women had BV. A nation-wide study
from Sweden14 found a RR of 3 (95% CI 1.3–7)
for postoperative infection after abdominalhyster-
ectomy for benign reasons among women with
BVcomparedtowomenwithoutBV.Inarecently
published study Lin and co-workers15 found an
increased risk of postoperative infection after all
major gynecological surgery if the patients had a
preoperativediagnosisofBV.In thatstudywomen
diagnosed with an intermediate flora had no
increased risk of postoperative infections.
The aims of this study are to investigate the
effect of pre- and postoperative metronidazole
treatment regarding the postoperative infection
rate among women with abnormal vaginal flora
compared to women with lactobacilli flora.
SUBJECTS AND METHODS
Study population
Thecurrentstudyincludedwomenundergoingan
elective total abdominal hysterectomy for benign
reasonsfrom1992to1996,less than50 yearsofage
or if over 50 still menstruating. We enrolled 213
patients into the study. Seventy-one of these were
excluded (Table 1). Exclusion criteria were pre-
operative antibiotic use within onemonthprior to
surgery, surgery for malignant disease and opera-
tions that for other reasons required preoperative
antibiotics. Twenty-two patients were excluded
for missing or inadequate vaginal smears, mostly
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Wrong randomization n
Supra vaginal hysterectomy
Postmenopausal
Declined study entry
Preoperative antibiotics
Malignant surgery
Total
10
1
15
5
3
34
Operative complications n
Preoperative antibiotics
Re-operation
Other intestinal surgery that required antibiotics
Total
6
1
2
9
Postoperative complications n
Antibiotics for pneumonia, cholecystis, ileus
Allergic reaction to metronidazole
Total
4
2
6
Smear problems n
Missing or uninterrupted smear, treatment
Missing or uninterrupted smear, no treatment
Total
13
9
22
Table 1 Excluded patients (n = 71)duetointerferingmenstrual blood.Welimited the
study to menstruating women, as the concept of
BV and intermediate flora are poorly understood
regarding postmenopausal women. No consider-
ation was taken as to whether the women were
menstruating due to sequential hormone replace-
ment therapy (HRT) or endogenous hormone
production.
Patient evaluation
Randomization was done according to Zelen16,
using sealed envelopes in blocksoften patientsand
carried out before informed consent. The nurse
asked patients at preoperative registration if they
wanted to join the study, before the patients met
the operating doctor at the final examination.
Thus, women randomized to the non-treatment
group were not asked to join the study, as no anti-
biotic treatment is the normal procedure at the
clinic.Womenrandomizedtothetreatment group
were askedtojointhestudyand receive treatment.
In some cases the operation method was changed
from the original planned total abdominal hyster-
ectomy to other types of hysterectomies after
randomization and the women were then
excludedfromthestudy.Thenormalpreoperative
procedure included a pelvic examination by the
attending physician where vaginal fluid was
obtained from the posterior fornix, placed on a
microscope slide, air-dried and stored at room
temperature. Demographic data, medical history
and physical findings were recorded on standard-
ized study forms. The vaginal slide was Gram
stained and analyzed accordingto Nugents scoring
system17 by one trained examiner without knowl-
edge of the postoperative outcome and all slides
were blindly batch analyzed after the study was
finished. No evaluation of the vaginal flora was
donepreoperatively and thedoctorhadno knowl-
edge of the vaginal status of the patient during
operation or at postoperative care. If postoperative
infectionoccurredthiswasrecordedbytheattend-
ing physician on the special form for the study.
Definitions
BV was defined according to Nugent’s criteria17 as
absence of lactobacilli and presence ofa Gardnerella
morphotype flora, with a Nugent’s score of
7–10. Women with a score of 0–3 were regarded
as normal and women with a score of 4–6 as
intermediate. Women with a diagnosis of BV or
intermediate flora were merged to a group called
abnormal vaginal flora.
Women were defined as having a post-
operative vaginal cuffinfection if they had three or
all ofthefollowingfoursigns duringgynecological
examination: (1) increased abdominal pain after
the second day of operation;(2) temperature more
than 38°C rectally after the third day; (3) malo-
dorousdischarge; and (4) induration or pain in the
vaginal vault.
Wound infection was defined as induration and
increased redness around the wound where anti-
biotic treatment or debridement where needed. If
a woman had both vaginal cuff and wound infec-
tion she was recorded as a vaginal cuff infection.
Urinary tract infection (UTI) was positive urinary
culture with more than 100 000 bacteria/ml.
Unexplained fever was defined as temperature
above 38°C after the third day of operation with-
out any other known diagnosis. All medical
records were scrutinized before the vaginal smears
were investigated.
Treatment and follow-up
On the evening before the operation the women
were given 1 g metronidazole rectally (FlagylÔ
suppositories 1 g, Rhône-Poulenc, Rorer,
Helsingborg) and the treatment was continued
every evening until the patient was discharged
from the gynecological ward or until any side-
effectswerenoticed.Themost commontreatment
for BV is 7-day treatment with oral metronidazole
with a dose of 500 mg BID. Because nausea is a
well known side-effect of orally administrated
metronidazole, we chose rectal administration
which has a slower reabsorption rate than oral
administration, but the dose of 1 g will give the
same serum concentration as oral treatment. The
gynecologist on duty in the ward performed the
operation. All the surgeons were specialists in
gynecology or were supervised by a senior doctor.
Total abdominal hysterectomy was performed
either bya low Cohen incisionorlow longitudinal
incision and the vaginal cuff was closed. All other
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recorded, i.e. bilateral salpingooophorectomy
(BSO) or incontinence surgery such as Burch
procedure.
Women over 50 years of age received anti-
thrombotic prophylaxis with low molecular
heparin. At the operating room the operating
nurse routinely cleaned the vagina preoperatively
with chlorhexidine solution just before the start of
the operation. A catheter (KAD) was left in the
bladder until the second day postoperatively.
Patientswerefree toeat assoonastheyfeltable.All
women were offered a follow-up visit 4–6 weeks
after the operation in the gynecological outpatient
clinic. All medical records from the follow-up
visits were scrutinized before the results from the
vaginal examinations were added.
Statistics
The Fisher exact test was used when less then 100
observations, otherwise thechisquare (c2) test was
used, together with RR with 95 % CI. A logistic
regression analysis and variance analysis was
performed.
Ethics
The study was approved by the regional ethics
committee at the University of Gothenburg and
the ‘Svenska läkemedelsverket’ (Swedish Medical
Products Agency). Women gave verbal informed
consent to participate in the study.
RESULTS
Thestudypopulationincluded142patients.There
were no differences in the demographic factors
between the treated and not treated group
(Table 2). There were no differences in operating
time, preoperative bleeding or preoperative blood
hemoglobin, and a logistic regression was per-
formed using these variables which showed that
preoperative hemoglobin, weight, operating time
and bleeding had no influence on the post-
operative infection rate for all three groups of
women (all women, non-treatment group and
treatment group). The indication for the hyster-
ectomywas dysfunctionaluterine bleeding(DUB)
or fibroids in more than 80% of cases.
The treatment consisted of metronidazole
rectally from the night before operation until dis-
charge from the hospital or at minimum 4 days of
treatment.Side-effectssuchasnauseawerenoticed
among eight (12%) of the 67 treated women.
These eight women discontinued the treatment in
advance but still after the required 4 days of treat-
ment. The mean treatment time was 5.8 days with
a range of 4–13 days. Two patients had an allergic
reaction after the first dose of treatment and were
excluded from the study (Table 1).
Themicroscopyofthevaginalflorashowedthat
41.5% of the women had abnormal vaginal flora
(17.6% of women with BV and 23.9% with inter-
mediate flora) and 58.5% had normal lactobacilli
flora.
The mean time for the postoperative follow-up
visit fornon-infectedwomenwas6.4 weekswitha
range of 4–12 weeks, except for two patients who
did not come to the scheduled visit. These two
patients were interviewed by telephone. Fourteen
women had a vaginal cuff infection, 13 of whom
werediagnosed beforedischargefromthehospital.
Only five of the ten wound infections had been
detected before leaving the hospital. Of 25 UTI,
21 were known before the patients left the
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All women
(n = 142)
Treatment group
(n = 67)
Non-treatment group
(n = 75)
Mean Range Mean Range Mean Range
Age (years)
Weight (kg)
Operating time (minutes)
Preoperative bleeding (ml)
Preoperative hemoglobin (g/l)
46
71
100
578
127
33–58
44–110
43–210
75–2400
83–154
46
73
99
580
127
33–58
44–110
43–210
100–2400
83–146
45
70
102
576
127
33–57
51–93
50–190
75–2300
89–154
Table 2 Background factorshospital. Fifteen patients left the hospital with a
slight increase in body temperature, however
without a specific diagnosis i.e. unexplained fever
and with no treatment. Four (26%) of these
patients came back with a UTI but none of
these patients had an undetected wound or cuff
infection.
There was no significant difference in wound
infection rate among the treated or non-treated
women (Table 3). The frequency of cuff infection
decreased from27 to0% in women with anabnor-
mal vaginal flora that were treated with
metronidazole (p < 0.05). This finding was even
more pronounced among women with BV as the
vaginal cuffinfection decreased from35.7 to 0% in
the metronidazole group (p < 0.05). The vaginal
cuff infection rate only decreased from 9.5 to 2%
for women with normal lactobacilli flora (not
significant) (Table3). Therewere no differences in
UTI rate between thevarious vaginal floragroups,
and treatment with metronidazole did not reduce
the incidence of postoperative UTI.
This study was performed when long post-
operative hospitalcare after abdominal hysterecto-
mies was common clinical practice. The mean
time for hospitalcare was 5.8 days (standard devia-
tion, SD 1.7) for women with no infection and
6.8 days (SD 3.5) for women with wound infec-
tion. Women with UTI stayed in hospital for
6.7 days(SD 1.7).Womenwithcuffinfectionshad
a mean hospital stay of 8.8 days (SD 2.4). Variance
analysis with Tukey’s pairwise comparisons
showed statistically significant longer hospital care
only for vaginal cuff infection (p < 0.01).
Intention-to-treat analysis for all 142 women
showed a significant difference regarding cuff
infections: one cuff infection (1.5%) in the treated
group versus 14 cuff infections (17%) in the
non-treated group (p < 0.05, c2 test). The relative
risk of postoperative cuff infection was signifi-
cantly lower in the treated group versus the
non-treated group (RR 0.1, 95% CI 0.01–0.6).
No difference was seen regarding the wound
infections or UTI.
DISCUSSION
Bacterial vaginosis (BV) isaconditioninwhichthe
vaginal flora is characterized by a 1000–10 000-
fold increase in concentrations of various
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Wound infection
Treatment group
n (%)
Non-treatment group
n (%) Fisher’s exact test Relative risk
Abnormal, n = 59
Lactobacilli, n = 83
All women, n = 142
3 (12)
3 (7)
6 (9)
1 (3)
3 (7)
4 (5.3)
ns
ns
ns*
-3.8 (0.4–34.5) ns
1 (0.2–4.6) ns
1.7 (0.5–5.7) ns
Cuff infection
Treatment group
n (%)
Non-treatment group
n (%)
Abnormal, n = 59
Lactobacilli, n = 83
All women, n = 142
0 (0)
1 (2)
1 (1.5)
9 (27)
4 (9.5)
13 (17.3)
0.003
ns
0.016*
Not possible
0.3 (0.03–2.2) ns
0.1 (0.01–0.6) p < 0.05
Urinary tract infections
Treatment group
n (%)
Non-treatment group
n (%)
Abnormal, n = 59
Lactobacilli, n = 83
All women, n = 142
7 (27)
5 (12)
12 (17.9)
4 (12)
9 (21)
13 (17.3)
ns
ns
ns*
1.8 (0.6–4.8) ns
0.6 (0.2–1.6) ns
1 (0.5–2.1) ns
*Fisher’s exact test except for ‘all women’: c
2test was used as there were more than 100 observations; ns, not significant
Table 3 Infection rate among women after abdominal hysterectomy and treatment with pre- and postoperative
metronidazole 1 g rectally for a minimum of 4 daysanaerobic bacteria. However, the vaginal flora of
women with ‘intermediate flora’ has an increased
concentration of bacteria of up to 1000 times7.
Houang and co-workers18showed that the magni-
tude of bacteria contamination duringoperation is
an important determinant in the development of
postoperative infection after abdominal hyster-
ectomy. This might be the theoretical explanation
of the increased risk of postoperative infection in
women with either BV or intermediate flora8–10 as
it might be the increased concentrationof bacteria
ratherthan thepathogenicpotentialof thebacteria
that causes the postoperative infection. When
diagnosing BV it is often most difficult to make a
clear distinction between full-blown BV and the
intermediate flora. This is apparent when using
Nugent scoring. According to Nugent’s scoring
system a score of six is given if there are one–four
lactobacilli per high power field even if there are
hundredsorthousandsofsmall bacteria inthesame
high power field. A slide with that many small
bacteria will also often have clue cells but this is
something that Nugent’s scoring system does not
take into account. This is the reason why inter-
mediate flora and BV in this study are merged into
one group called abnormal vaginal flora. This
merging was successful in an earlier study where
women with lactobacilli flora did not benefit from
preoperative clindamycin treatment before legal
abortion, in contrast to women with abnormal
vaginal flora defined as BV or intermediate flora10.
To simplify the diagnosis in a practical clinical
aspect it might be helpful to focus on the presence
of lactobacilli. Women with a microscopic finding
of vaginal flora of normal lactobacilli will receive
no treatment whereas women in absence of
normal lactobacilli flora will receive preoperative
treatment.
Lin and co-workers15 did not find any effect of
preoperative antibiotic treatment in the inter-
mediate group. This could be due to the fact that
they did not exclude postmenopausal women.
Postmenopausal women lack lactobacilli in the
vaginal flora and will score as intermediate flora
according to Nugent. An earlier nationwide study
showed that postmenopausal women have a lower
risk of postoperative infection than younger
women14. In this study we have therefore deliber-
ately restricted menstruating or estrogen-replaced
women as the concept of BV and intermediate
flora are poorly understood in postmenopausal
women.
Today, hospital care has shortened in most
places and patients are discharged much earlier
from hospital. In addition, a higher degree of
hysterectomies today are done either laparo-
scopically or vaginally, both with considerably
shorter hospital care than abdominal hyster-
ectomies. This is important to bear in mind when
postoperative infection rates are reported and
compared, as many postoperative infections do
not arise until after discharge from hospital and
therefore will alter documented infection rates.
In an open randomized trial there are always
some methodological weaknesses. When the
doctor in charge of the patient knows whether or
not the patient is treated it might influence the
results: if a patient with a suspected mild infection
received metronidazole preoperatively, the doctor
may wait one day before diagnosis. And patients
known to have not been given metronidazole
preoperatively might be given other antibiotics
sooner. It could therefore be easier to diagnose a
postoperativeinfection if thewomen had no treat-
ment.Howeverthiswouldhaveaffectedtheinfec-
tionratesinthetreatedandnot-treatedgroups,and
not the difference between lactobacilli or abnor-
mal vaginal flora group as the diagnosis of the
vaginal flora was unknown to the doctor. The
definition of postoperative infection is subjective,
as always in open clinical studies, and our fre-
quency of postoperative infection could only be
compared with other hospitals with caution. The
subjective definition of postoperative infection
would only reduce any difference in the treatment
groups and would therefore weaken our results
but not affect the conclusion of the study.
There are many different treatment regimens
for BV. One commonly seen is 4 g metronidazole
given as a single 2 g dose on day one and three.
Because of this we required at least 4 days of
treatment for evaluation of efficacy, i.e. 4 g
metronidazole. Treatment with oral metro-
nidazole is known to cause nausea, a well-known
effect even of general anesthesia. Therefore we
decided to administer metronidazole rectally
instead of orally, to minimize exclusions due to
medical events.
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and intermediate flora among women operated
with abdominal hysterectomy. We showed that
womenwithBV orintermediateflorabenefitfrom
antibiotic treatment and should be offered treat-
ment starting the day before operation. Although
our intention-to-treat analysis showed that all
women, even those with normal lactobacilli flora,
would benefit from treatment to some degree, it
is questionable whether women with normal
lactobacilli flora should be given antibiotic treat-
ment for four days. We found no effect on the
frequency of wound infections or UTI. These
results were expected as UTI and wound infec-
tionsare mostly causedbyaerobicbacteria resistant
to metronidazole.
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